mcl
Showing 1 - 6 of 6
Mantle Cell Lymphoma, MCL Trial in United States (Tafasitamab, Lenalidomide)
Recruiting
- Mantle Cell Lymphoma
- MCL
-
Basking Ridge, New Jersey
- +6 more
Mar 27, 2023
CLL, SLL, Richter's Transformation Trial in United States (TG-1801, Ublituximab)
Recruiting
- CLL
- +9 more
- TG-1801
- Ublituximab
-
Fayetteville, Arkansas
- +4 more
Jan 20, 2023
Multiparametric Cardiac MRI in Patients Under CAR T-cell Therapy
Recruiting
- DLBCL
- +8 more
- Cardiac MRI
-
Bonn, NRW, GermanyUniversity Hospital Bonn
Jun 11, 2022
MCL, Mantle Cell Lymphoma Trial in Worldwide (Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma)
Recruiting
- MCL
- Mantle Cell Lymphoma
- Acalabrutinib-rituximab in patients with untreated mantle cell lymphoma
-
Odense, Denmark
- +21 more
Feb 11, 2022
DLBCL, MCL, Recurrent Disease Trial in Meldola (90Y-DOTATOC)
Terminated
- DLBCL
- +2 more
-
Meldola, FC, ItalyNuclear Medicin Division, IRST IRCCS
Mar 16, 2018